HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 50 filers reported holding HAEMONETICS CORP MASS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,020,343 | +1.6% | 39,207,000 | 0.0% | 0.38% | -4.0% |
| Q2 2023 | $33,498,151 | +85.8% | 39,207,000 | +84.9% | 0.40% | +86.9% |
| Q1 2023 | $18,032,373 | +52.4% | 21,207,000 | +49.3% | 0.21% | +73.2% |
| Q4 2022 | $11,834,287 | +28.8% | 14,207,000 | +24.0% | 0.12% | +24.2% |
| Q3 2022 | $9,185,000 | – | 11,457,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 18,000,000 | $15,705,000 | 1.15% |
| Context Capital Management, LLC | 14,558 | $12,660 | 1.02% |
| Quaero Capital S.A. | 1,200,000 | $1,042,440 | 0.99% |
| READYSTATE ASSET MANAGEMENT LP | 22,200,000 | $19,369,500 | 0.97% |
| DeepCurrents Investment Group LLC | 24,371,000 | $21,212,517 | 0.92% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,904,000 | $34,816,240 | 0.81% |
| SSI INVESTMENT MANAGEMENT LLC | 10,872,000 | $9,431,462 | 0.77% |
| Empyrean Capital Partners, LP | 13,500,000 | $11,696,959 | 0.72% |
| MACKAY SHIELDS LLC | 29,294,000 | $25,825,110 | 0.71% |
| Aequim Alternative Investments LP | 20,500,000 | $17,886,250 | 0.68% |